Researcher
Piet Ost
- Keywords:Radiotherapy, Prostate Cancer
- Disciplines:Cancer therapy, Palliative care and end-of-life care, Urology, Radiation therapy
Affiliations
- Department of Human Structure and Repair (Department)
Member
From1 Oct 2018 → Today - Dean's Office of the Faculty of Medicine and Health Sciences (Administrative office)
Member
From1 Jul 2012 → 30 Sep 2012 - Department of Radiation oncology and experimental cancer research (Department)
Member
From1 Nov 2008 → 30 Sep 2018
Projects
1 - 10 of 13
- Omics analysis in liquid biopsy samples of advanced tumoursFrom1 Nov 2023 → TodayFunding: BOF - doctoral mandates
- Digital pathology as a proxy for molecular profiling of prostate tumorsFrom1 Oct 2022 → TodayFunding: BOF - projects
- Detection of biomarkers to reduce radiation-induced toxicities and improve clinical outcomes, with emphasis on the role of unintended dose.From1 Sep 2022 → 31 Aug 2023Funding: Nonprofit institution or equivalents
- Study of the molecular mechanisms of metastasis in prostate cancer.From1 Oct 2021 → 31 Jan 2022Funding: BOF - doctoral mandates
- ProBio: an outcome-adaptive, multi-arm, open-label, multiple assignment randomized biomarker-driven trial in patients with metastatic castration-resistant prostate cancerFrom1 Feb 2020 → 31 Jan 2024Funding: Nonprofit institution or equivalents
- A data-driven integrative framework for the identification of cancer driver pathways and their mode of action.From1 Nov 2019 → 31 Oct 2023Funding: FWO Strategic Basic Research Grant
- CHEckpoint inhibition in combination with an immunoboost of External body adiotherapy in oligometastatic or oligoprogressive Solid tumors: CHEERS-trialFrom1 Jul 2018 → 30 Jun 2023Funding: Nonprofit institution or equivalents
- Effect and process evaluation of an intervention program on physical activity and sedentary behavior in castrate resistant prostate cancer patientsFrom1 Oct 2017 → 30 Sep 2022Funding: FWO fellowships
- PEACE V: a randomized phase III trial for the Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM)From1 Jan 2017 → 31 Oct 2021Funding: BOF - Doctoral projects
- A randomized phase II trial for the Treatment of Oligorecurrent nodal prostate cancer: TOREN-trial.From1 Jan 2017 → 31 Dec 2021Funding: Foundations, funds and other with scientific goal
Publications
21 - 30 of 243
- Progression-directed therapy for oligoprogression in castration-refractory prostate cancer(2021)
Authors: Charlien Berghen, Steven Joniau, Piet Ost, Kenneth Poels, Wouter Everaerts, Karin Haustermans, Gaëtan Devos, Gert De Meerleer
Pages: 305 - 309 - Multifocality in prostate cancer : implications for PAM50 subtyping using an index lesion-only approach(2021)
Authors: Jan Vanwelkenhuyzen, Nicolaas Lumen, Kathleen Marchal, Piet Ost, Bram De Laere
Number of pages: 1 - Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer(2020)
Authors: Sarah Piron, Kathia De Man, Vanessa Schelfhout, Nick Van Laeken, Ken Kersemans, Eric Achten, Filip De Vos, Piet Ost
- Tracking the origins of metastatic seeding in de novo metastatic prostate cancer(2020)
Authors: Kim Van der Eecken, Evan Warner, Nicolaas Lumen, Matti Annala, Andrew Murtha, Elena Schönlau, Nicolette Fonseca, Cameron Herberts, Jan Vanwelkenhuyzen, Wesley Verla, et al.
Number of pages: 1 - A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer(2020)
Authors: Elise De Bleser, Ruben Willems, Karel Decaestecker, Lieven Annemans, Aurélie De Bruycker, Valerie Fonteyne, Nicolaas Lumen, Filip Ameye, Ignace Billiet, Steven Joniau, et al.
- A deep learning approach validates genetic risk factors for late toxicity after prostate cancer radiotherapy in a REQUITE Multi-National Cohort(2020)
Authors: Michela Carlotta Massi, Francesca Gasperoni, Francesca Ieva, Anna Maria Paganoni, Paolo Zunino, Andrea Manzoni, Nicola Rares Franco, Piet Ost, Christopher J. Talbot, Tim Rattay, et al.
- The ProBio trial : molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer(2020)
Authors: Alessio Crippa, Bram De Laere, Andrea Discacciati, Berit Larsson, Jason T. Connor, Erin E. Gabriel, Camilla Thellenberg, Elin Janes, Gunilla Enblad, Anders Ullen, et al.
- Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer : a systematic review(2020)
Authors: Verane Achard, Marta Bottero, Michel Rouzaud, Andrea Lancia, Marta Scorsetti, Andrea Riccardo Filippi, Ciro Franzese, Barbara Alicja Jereczek-Fossa, Gianluca Ingrosso, Piet Ost, et al.
Pages: 1224 - 1234 - Radium-223 within the evolving treatment options for metastatic castration-resistant prostate cancer : recommendations from a European expert working group(2020)
Authors: Joe M. O'Sullivan, Joan Carles, Richard Cathomas, Alfonso Gomez-Iturriaga, Daniel Heinrich, Gero Kramer, Piet Ost, Inge van Oort, Bertrand Tombal
Pages: 455 - 463 - PETU+2013CT for staging patients with muscle invasive bladder cancer : is it more than just a fancy tool?(2020)
Authors: Kathia De Man, Pieter De Visschere, P. Dirix, G. De Meerleer, C. Berghen, Piet Ost
Pages: 83 - 94